Sign inJoin waitlistJoin the waitlist

Casey Cosgrove

Associate Fellowship Research Director · Ohio State University Hospital

Credentials: · · · ·

History

Ohio State University Hospital
Present

Gynecologic Oncology
Ohio State University Hospital
2019–2022
Obstetrics and Gynecology
2015–2019
Doctor of Medicine
2008–2012

Research

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
New England Journal of Medicine · 2023 · 405 citations
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Gynecologic Oncology · 2017 · First of 18 authors · 107 citations
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Gynecologic Oncology · 2018 · First of 20 authors · 101 citations

David Cohn
50 papers
Floor Backes
42 papers
David O'Malley
38 papers
Larry Copeland
30 papers
Kristin Bixel
25 papers
Paulina Haight
23 papers · 23 as a fellow
Christa Nagel
22 papers
Adrian Suarez
17 papers
Ritu Salani
12 papers
Molly Morton
11 papers · 11 as a fellow
David Barrington
10 papers · 10 as a resident
JC
Julia Chalif
10 papers · 10 as a fellow

Grants

Combined NGS Tumor-Based Detection of Germline Lynch Syndrome Mutations and Prognostic Classification of Endometrial Cancers
National Cancer Institute · R01
PI · $925.1K · Ohio State University
2018–2024

Clinical trials

Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma
Principal investigator · Active not recruiting · Phase 2
Casey Cosgrove
2023–2026
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2022–2027